美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

PMGC Holdings

1.78

+0.12007.23%

盤後：1.72-0.0600-3.37%19:59 EDT

成交量：31.16萬

成交額：53.81萬

市值：808.80萬

市盈率：-0.02

高：1.79

開：1.68

低：1.66

收：1.66

52周最高：309.12

52周最低：1.62

股本：454.38萬

流通股本：454.09萬

量比：0.52

換手率：6.86%

股息：- -

股息率：- -

每股收益(TTM):-85.5296

每股收益(LYR):-6,592.3866

淨資產收益率：-107.90%

總資產收益率：-33.28%

市淨率：0.64

市盈率(LYR):0.00

資料載入中...

總覽公司新聞資訊公告

Elevai Labs Q1營收大幅下滑，淨虧損擴大

环球市场播报

納斯達克上市公司PMGC Holdings發布2026年第一季度財報並提交10-Q表格；總資產突破2600萬美元，較2025年底激增102%，按年飆升193%

諾思創生物科學提交新美國專利申請涵蓋EL-22製劑及給藥方案用於治療GLP-1相關肌肉萎縮、少肌症、肌肉廢用性萎縮及特定神經系統疾病

Svm Machining與Turbo-Jet Products簽署長期協議，供應航空航天與國防關鍵部件

PMGC Holdings簽署4000萬美元股權融資協議宣佈加速航空航天與國防制造領域併購戰略

Northstrive Biosciences宣佈EL-32工作細胞庫運抵美國並啓動與Modulant Biosciences合作的雙重肌生長抑制素資產生產工藝優化，旨在結合GLP-1療法實現肌肉保護

PMGC Holdings旗下Northstrive保留EL-32人權授權 Modulant獲獨家動物健康許可

Aga Precision Systems 再籤長期供應協議為一階供應商製造航空航天與國防部件

BUZZ--美國股票走勢-泰森食品公司、Atmus 過濾公司、安飛士預算公司

BUZZ-PMGC 控股公司子公司獲得無人機技術選擇權，股價下跌

Northstrive Defense Tech 獲得多領域無人機載荷技術選項，用於國防與商業應用

PMGC Holdings Inc.宣佈成立新子公司Northstrive Defense Tech，瞄準高增長的國防、無人機及自主系統領域

PMGC Holdings與Turbo-Jet Products簽署長期協議，供應關鍵航空航天與國防部件

PMGC Holdings [納斯達克: ELAB] 公布2025年度業績並提交10-K表格，公司資產規模擴大至1380萬美元，較2024年增長43%

Northstrive Biosciences與Moa Life Plus簽署許可協議修正案，共同開發靶向肌肉保留的雙重肌肉生長抑制素資產，以聯合GLP-1療法

SVM Machining公司成功獲得ITAR註冊資格，正式進軍美國國防制造合同領域

Northstrive Biosciences啓動El-32臨床前研究，評估GLP-1減重療法中的肌肉保護作用

Northstrive Biosciences簽署最終許可協議，推進肌肉抑制素工程益生菌El-22與El-32在動物健康領域的商業化進程

PMGC Holdings旗下Northstrive Biosciences與Modulant Biosciences達成許可協議

Pmgc Holdings Inc.盤中異動股價大跌6.09%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ELAB/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELAB\",,,,,undefined,":{"symbol":"ELAB","market":"US","secType":"STK","nameCN":"PMGC Holdings","latestPrice":1.78,"timestamp":1779480000000,"preClose":1.66,"halted":0,"volume":311565,"hourTrading":{"tag":"盘后","latestPrice":1.72,"preClose":1.78,"latestTime":"19:59 EDT","volume":49362,"amount":88310.9073,"timestamp":1779494376555,"change":-0.06,"changeRate":-0.033708,"amplitude":0.073034},"delay":0,"changeRate":0.07228915662650609,"floatShares":4540900,"shares":4543800,"eps":-85.529594,"marketStatus":"美國陣亡戰士紀念日休市","change":0.12,"latestTime":"05-22 16:00:00 EDT","open":1.68,"high":1.79,"low":1.66,"amount":538118.9600895001,"amplitude":0.078313,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-85.529594,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":7,"adr":0,"listingDate":1700542800000,"exchange":"NASDAQ","adjPreClose":1.66,"preHourTrading":{"tag":"盘前","latestPrice":1.66,"preClose":1.66,"latestTime":"09:29 EDT","volume":13465,"amount":22337.8034915,"timestamp":1779456576103,"change":0,"changeRate":0,"amplitude":0.039639},"postHourTrading":{"tag":"盘后","latestPrice":1.72,"preClose":1.78,"latestTime":"19:59 EDT","volume":49362,"amount":88310.9073,"timestamp":1779494376555,"change":-0.06,"changeRate":-0.033708,"amplitude":0.073034},"volumeRatio":0.5172331455955748},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELAB\",,,,,undefined,":{"symbol":"ELAB","floatShares":4540900,"roa":"-33.28%","roe":"-107.90%","lyrEps":-6592.386648,"volumeRatio":0.5172331455955748,"shares":4543800,"dividePrice":0,"high":1.79,"amplitude":0.078313,"preClose":1.66,"low":1.66,"week52Low":1.62,"pbRate":"0.64","psRate":"6.36","week52High":309.12,"institutionHeld":0,"latestPrice":1.78,"eps":-85.529594,"divideRate":0,"volume":311565,"delay":0,"ttmEps":-85.529594,"open":1.68,"prevYearClose":35.52,"prevWeekClose":1.78,"prevMonthClose":2.46,"prevQuarterClose":5.99,"fiveDayClose":2.08,"twentyDayClose":2.49,"sixtyDayClose":7.56},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELAB\",params:#limit:5,,,undefined,":[{"date":"2026-05-15","symbol":"ELAB","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778832000000,"name":null,"time":"盤前","dateTimestamp":1778817600000,"actualEps":null},{"date":"2026-03-30","symbol":"ELAB","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774857600000,"name":null,"time":"盤前","dateTimestamp":1774843200000,"actualEps":null},{"market":"US","date":"2026-03-10","symbol":"ELAB","defaultRemindTime":1773149400000,"type":"split","dateTimestamp":1773115200000,"forFactor":6,"toFactor":1,"ratio":6},{"market":"US","date":"2026-01-06","symbol":"ELAB","defaultRemindTime":1767709800000,"type":"split","dateTimestamp":1767675600000,"forFactor":4,"toFactor":1,"ratio":4},{"market":"US","date":"2025-11-14","symbol":"ELAB","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-4.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELAB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELAB","date":"2026-05-22","current":-0.020812,"percent":0.552066,"low":-19.933298,"twenty":-2.495456,"median":-0.797632,"eighty":-0.438798,"high":-0.098848,"avg":-1.705366,"sd":2.596837,"marketCap":7542626},"quantilePoints":[{"date":"2023-11-24","current":-18.255744,"twenty":-17.959705,"median":-17.515646,"eighty":-17.071587,"marketCap":64119575},{"date":"2023-12-01","current":-13.864497,"twenty":-19.360956,"median":-18.255744,"eighty":-16.918634,"marketCap":48696218},{"date":"2023-12-08","current":-10.509387,"twenty":-18.255744,"median":-15.443372,"eighty":-11.703412,"marketCap":36912079},{"date":"2023-12-15","current":-8.308155,"twenty":-18.10279,"median":-11.940243,"eighty":-9.335099,"marketCap":31539899},{"date":"2023-12-22","current":-8.354717,"twenty":-17.34789,"median":-10.682077,"eighty":-8.450306,"marketCap":31716661},{"date":"2023-12-29","current":-8.216856,"twenty":-16.918634,"median":-10.164008,"eighty":-8.299025,"marketCap":31193307},{"date":"2024-01-05","current":-7.303872,"twenty":-15.709807,"median":-9.153506,"eighty":-8.280766,"marketCap":27727384},{"date":"2024-01-12","current":-8.125558,"twenty":-14.012516,"median":-8.832664,"eighty":-8.070779,"marketCap":30846714},{"date":"2024-01-19","current":-4.884465,"twenty":-13.479646,"median":-8.376629,"eighty":-7.906442,"marketCap":18542688},{"date":"2024-01-26","current":-3.42369,"twenty":-11.881035,"median":-8.330979,"eighty":-7.359564,"marketCap":12997211},{"date":"2024-02-02","current":-3.834533,"twenty":-11.486317,"median":-8.216856,"eighty":-4.738387,"marketCap":14556876},{"date":"2024-02-09","current":-2.921549,"twenty":-10.785691,"median":-8.079909,"eighty":-3.801666,"marketCap":11090953},{"date":"2024-02-16","current":-3.323718,"twenty":-10.440311,"median":-7.942961,"eighty":-3.414564,"marketCap":12617692},{"date":"2024-02-23","current":-3.218269,"twenty":-10.164008,"median":-7.897312,"eighty":-3.378041,"marketCap":12217378},{"date":"2024-03-01","current":-3.181749,"twenty":-9.179141,"median":-7.443102,"eighty":-3.218269,"marketCap":12078741},{"date":"2024-03-08","current":-3.378041,"twenty":-9.127872,"median":-4.975763,"eighty":-3.263918,"marketCap":12823915},{"date":"2024-03-15","current":-3.555616,"twenty":-8.855945,"median":-4.679044,"eighty":-3.323718,"marketCap":13498037},{"date":"2024-03-22","current":-3.491707,"twenty":-8.832664,"median":-3.834533,"eighty":-3.332848,"marketCap":13255422},{"date":"2024-03-28","current":-3.149795,"twenty":-8.668692,"median":-3.638241,"eighty":-3.254788,"marketCap":11957434},{"date":"2024-04-05","current":-2.739531,"twenty":-8.426843,"median":-3.539867,"eighty":-3.191975,"marketCap":11784138},{"date":"2024-04-12","current":-2.578785,"twenty":-8.359099,"median":-3.514988,"eighty":-3.15016,"marketCap":11092686},{"date":"2024-04-19","current":-2.356802,"twenty":-8.353987,"median":-3.494218,"eighty":-3.138017,"marketCap":10137824},{"date":"2024-04-26","current":-2.715358,"twenty":-8.317285,"median":-3.457927,"eighty":-2.966103,"marketCap":11680160},{"date":"2024-05-03","current":-2.840249,"twenty":-8.271636,"median":-3.430537,"eighty":-2.908834,"marketCap":12217378},{"date":"2024-05-10","current":-2.751214,"twenty":-8.225986,"median":-3.400866,"eighty":-2.810275,"marketCap":11834394},{"date":"2024-05-17","current":-2.439543,"twenty":-8.198597,"median":-3.378041,"eighty":-2.734696,"marketCap":11265982},{"date":"2024-05-24","current":-2.476318,"twenty":-8.139253,"median":-3.346086,"eighty":-2.649774,"marketCap":11435812},{"date":"2024-05-31","current":-2.456058,"twenty":-8.070779,"median":-3.333761,"eighty":-2.615446,"marketCap":11342250},{"date":"2024-06-07","current":-2.620224,"twenty":-8.03426,"median":-3.293818,"eighty":-2.590871,"marketCap":12100380},{"date":"2024-06-14","current":-2.536364,"twenty":-7.99774,"median":-3.211422,"eighty":-2.574044,"marketCap":11713111},{"date":"2024-06-21","current":-2.409546,"twenty":-7.933831,"median":-3.194759,"eighty":-2.543297,"marketCap":11127455},{"date":"2024-06-28","current":-2.408319,"twenty":-7.915572,"median":-3.18814,"eighty":-2.539819,"marketCap":11121788},{"date":"2024-07-05","current":-2.340001,"twenty":-7.897312,"median":-3.163489,"eighty":-2.517446,"marketCap":10806289},{"date":"2024-07-12","current":-2.148137,"twenty":-7.860792,"median":-3.149795,"eighty":-2.484198,"marketCap":9920249},{"date":"2024-07-15","current":-2.063455,"twenty":-7.842533,"median":-3.149795,"eighty":-2.476543,"marketCap":9529182},{"date":"2024-08-02","current":-1.8,"twenty":-7.824273,"median":-3.149795,"eighty":-2.472639,"marketCap":8312530},{"date":"2024-08-09","current":-1.490993,"twenty":-7.627068,"median":-3.134046,"eighty":-2.438304,"marketCap":6885510},{"date":"2024-08-16","current":-1.275527,"twenty":-7.359564,"median":-3.024259,"eighty":-2.416511,"marketCap":6059653},{"date":"2024-08-23","current":-0.996722,"twenty":-6.536966,"median":-2.921549,"eighty":-2.408074,"marketCap":4735130},{"date":"2024-08-30","current":-1.174958,"twenty":-5.249658,"median":-2.921549,"eighty":-2.362653,"marketCap":5581877},{"date":"2024-09-06","current":-1.375091,"twenty":-4.920984,"median":-2.840249,"eighty":-2.345852,"marketCap":6532648},{"date":"2024-09-13","current":-1.357574,"twenty":-4.774907,"median":-2.7913,"eighty":-2.312486,"marketCap":6449430},{"date":"2024-09-20","current":-1.33918,"twenty":-4.674479,"median":-2.751214,"eighty":-2.26391,"marketCap":6362050},{"date":"2024-09-27","current":-0.556488,"twenty":-4.272766,"median":-2.706294,"eighty":-1.721618,"marketCap":2643710},{"date":"2024-10-04","current":-0.825353,"twenty":-3.907572,"median":-2.663183,"eighty":-1.516044,"marketCap":3921009},{"date":"2024-10-11","current":-0.609011,"twenty":-3.809883,"median":-2.623475,"eighty":-1.448755,"marketCap":2893229},{"date":"2024-10-18","current":-0.543983,"twenty":-3.700324,"median":-2.618669,"eighty":-1.401366,"marketCap":2584301},{"date":"2024-10-25","current":-0.958273,"twenty":-3.624547,"median":-2.598328,"eighty":-1.356698,"marketCap":4552470},{"date":"2024-10-31","current":-0.965548,"twenty":-3.591497,"median":-2.58341,"eighty":-1.330061,"marketCap":4587034},{"date":"2024-11-08","current":-0.186042,"twenty":-3.543017,"median":-2.570883,"eighty":-1.290658,"marketCap":883831},{"date":"2024-11-15","current":-0.272307,"twenty":-3.520466,"median":-2.545057,"eighty":-1.259215,"marketCap":1293652},{"date":"2024-11-22","current":-1.912035,"twenty":-3.514988,"median":-2.532982,"eighty":-1.195453,"marketCap":10456757},{"date":"2024-11-29","current":-0.970216,"twenty":-3.514075,"median":-2.507089,"eighty":-1.176604,"marketCap":5306027},{"date":"2024-12-06","current":-0.979681,"twenty":-3.507684,"median":-2.495456,"eighty":-1.057426,"marketCap":5357793},{"date":"2024-12-13","current":-1.055406,"twenty":-3.495725,"median":-2.476318,"eighty":-1.052022,"marketCap":5771922},{"date":"2024-12-20","current":-1.320411,"twenty":-3.487233,"median":-2.449166,"eighty":-1.053364,"marketCap":7221213},{"date":"2024-12-27","current":-1.354124,"twenty":-3.469339,"median":-2.436446,"eighty":-1.055406,"marketCap":7405585},{"date":"2025-01-03","current":-1.393455,"twenty":-3.460209,"median":-2.417636,"eighty":-1.071656,"marketCap":7620685},{"date":"2025-01-10","current":-1.18556,"twenty":-3.45108,"median":-2.415433,"eighty":-1.087177,"marketCap":6483728},{"date":"2025-01-17","current":-1.208035,"twenty":-3.441037,"median":-2.409546,"eighty":-1.102066,"marketCap":6606642},{"date":"2025-01-24","current":-1.112516,"twenty":-3.431907,"median":-2.407092,"eighty":-1.109145,"marketCap":6084256},{"date":"2025-01-31","current":-0.955191,"twenty":-3.419127,"median":-2.368422,"eighty":-1.085209,"marketCap":5223856},{"date":"2025-02-07","current":-1.039472,"twenty":-3.407716,"median":-2.352273,"eighty":-1.05223,"marketCap":5684785},{"date":"2025-02-14","current":-0.955191,"twenty":-3.391736,"median":-2.340001,"eighty":-1.033105,"marketCap":5223856},{"date":"2025-02-21","current":-0.915859,"twenty":-3.378041,"median":-2.326586,"eighty":-0.998824,"marketCap":5008756},{"date":"2025-02-28","current":-0.668633,"twenty":-3.378041,"median":-2.304429,"eighty":-0.984457,"marketCap":3656699},{"date":"2025-03-07","current":-0.406293,"twenty":-3.378041,"median":-2.256137,"eighty":-0.973171,"marketCap":2221982},{"date":"2025-03-14","current":-0.413918,"twenty":-3.37165,"median":-2.063455,"eighty":-0.968145,"marketCap":2263682},{"date":"2025-03-21","current":-0.675785,"twenty":-3.34426,"median":-1.851285,"eighty":-0.96081,"marketCap":3695808},{"date":"2025-03-28","current":-0.778466,"twenty":-3.336318,"median":-1.604046,"eighty":-0.955191,"marketCap":4257365},{"date":"2025-04-04","current":-0.500407,"twenty":-3.333578,"median":-1.540289,"eighty":-0.934537,"marketCap":3125408},{"date":"2025-04-11","current":-0.363417,"twenty":-3.331022,"median":-1.490993,"eighty":-0.836712,"marketCap":2269810},{"date":"2025-04-17","current":-0.292093,"twenty":-3.323718,"median":-1.4582,"eighty":-0.778466,"marketCap":1824333},{"date":"2025-04-25","current":-0.251335,"twenty":-3.263918,"median":-1.443055,"eighty":-0.679871,"marketCap":1569775},{"date":"2025-05-02","current":-0.270582,"twenty":-3.218269,"median":-1.417569,"eighty":-0.675289,"marketCap":1689983},{"date":"2025-05-09","current":-0.266053,"twenty":-3.204574,"median":-1.39741,"eighty":-0.646723,"marketCap":1661699},{"date":"2025-05-16","current":-0.262826,"twenty":-3.194988,"median":-1.384287,"eighty":-0.595535,"marketCap":1697054},{"date":"2025-05-23","current":-0.3205,"twenty":-3.194531,"median":-1.364277,"eighty":-0.557113,"marketCap":2069451},{"date":"2025-05-30","current":-0.451578,"twenty":-3.184305,"median":-1.354754,"eighty":-0.542732,"marketCap":2915816},{"date":"2025-06-06","current":-0.457969,"twenty":-3.174445,"median":-1.33918,"eighty":-0.520246,"marketCap":2957077},{"date":"2025-06-13","current":-0.462229,"twenty":-3.158012,"median":-1.322196,"eighty":-0.515702,"marketCap":2984585},{"date":"2025-06-20","current":-0.447318,"twenty":-3.151895,"median":-1.320411,"eighty":-0.500505,"marketCap":2888308},{"date":"2025-06-27","current":-0.462229,"twenty":-3.149977,"median":-1.313781,"eighty":-0.487953,"marketCap":2984585},{"date":"2025-07-03","current":-0.477139,"twenty":-3.149795,"median":-1.303555,"eighty":-0.473305,"marketCap":3080862},{"date":"2025-07-11","current":-0.48353,"twenty":-3.149247,"median":-1.292317,"eighty":-0.477139,"marketCap":3122123},{"date":"2025-07-18","current":-0.48779,"twenty":-3.145321,"median":-1.284002,"eighty":-0.477139,"marketCap":3149631},{"date":"2025-07-25","current":-0.49205,"twenty":-3.13537,"median":-1.275385,"eighty":-0.477991,"marketCap":3177139},{"date":"2025-08-01","current":-0.445188,"twenty":-3.121036,"median":-1.227076,"eighty":-0.474583,"marketCap":2874554},{"date":"2025-08-08","current":-0.401521,"twenty":-3.076573,"median":-1.214986,"eighty":-0.469471,"marketCap":2592600},{"date":"2025-08-15","current":-0.49292,"twenty":-3.005452,"median":-1.208035,"eighty":-0.467341,"marketCap":2763708},{"date":"2025-08-22","current":-0.500521,"twenty":-2.954964,"median":-1.18556,"eighty":-0.469471,"marketCap":2806323},{"date":"2025-08-29","current":-0.495224,"twenty":-2.921549,"median":-1.178457,"eighty":-0.470749,"marketCap":2776626},{"date":"2025-09-05","current":-0.329897,"twenty":-2.921549,"median":-1.174323,"eighty":-0.466061,"marketCap":1849668},{"date":"2025-09-12","current":-0.361676,"twenty":-2.921549,"median":-1.157467,"eighty":-0.462229,"marketCap":2027848},{"date":"2025-09-19","current":-0.461553,"twenty":-2.908834,"median":-1.129373,"eighty":-0.459878,"marketCap":2587839},{"date":"2025-09-26","current":-0.607461,"twenty":-2.85443,"median":-1.100858,"eighty":-0.45834,"marketCap":3405918},{"date":"2025-10-03","current":-0.656976,"twenty":-2.836945,"median":-1.075718,"eighty":-0.459878,"marketCap":3683538},{"date":"2025-10-10","current":-0.736683,"twenty":-2.82357,"median":-1.05413,"eighty":-0.46039,"marketCap":4130438},{"date":"2025-10-17","current":-0.939573,"twenty":-2.810275,"median":-1.051814,"eighty":-0.461688,"marketCap":5268001},{"date":"2025-10-24","current":-0.810904,"twenty":-2.759352,"median":-1.034145,"eighty":-0.462229,"marketCap":4546579},{"date":"2025-10-31","current":-0.800286,"twenty":-2.756693,"median":-1.007232,"eighty":-0.462229,"marketCap":4487049},{"date":"2025-11-07","current":-0.719328,"twenty":-2.748877,"median":-0.99388,"eighty":-0.462392,"marketCap":4033135},{"date":"2025-11-14","current":-0.731273,"twenty":-2.734696,"median":-0.983285,"eighty":-0.463309,"marketCap":4100106},{"date":"2025-11-21","current":-0.52978,"twenty":-2.711732,"median":-0.978673,"eighty":-0.464678,"marketCap":3549457},{"date":"2025-11-28","current":-0.589755,"twenty":-2.697229,"median":-0.972047,"eighty":-0.465954,"marketCap":3951282},{"date":"2025-12-05","current":-0.553104,"twenty":-2.663795,"median":-0.970216,"eighty":-0.466489,"marketCap":3705722},{"date":"2025-12-12","current":-0.456477,"twenty":-2.663183,"median":-0.965515,"eighty":-0.466489,"marketCap":3058337},{"date":"2025-12-19","current":-0.242122,"twenty":-2.655536,"median":-0.96081,"eighty":-0.462229,"marketCap":1622183},{"date":"2025-12-26","current":-0.177704,"twenty":-2.632488,"median":-0.955191,"eighty":-0.461262,"marketCap":1190593},{"date":"2026-01-02","current":-0.164376,"twenty":-2.622825,"median":-0.955191,"eighty":-0.457372,"marketCap":1101299},{"date":"2026-01-09","current":-0.154658,"twenty":-2.620016,"median":-0.948505,"eighty":-0.454987,"marketCap":1036187},{"date":"2026-01-16","current":-0.103013,"twenty":-2.619153,"median":-0.932716,"eighty":-0.451373,"marketCap":690171},{"date":"2026-01-23","current":-0.642466,"twenty":-2.615446,"median":-0.915859,"eighty":-0.451578,"marketCap":4304435},{"date":"2026-01-30","current":-0.589369,"twenty":-2.605938,"median":-0.857118,"eighty":-0.451636,"marketCap":3948697},{"date":"2026-02-06","current":-0.28318,"twenty":-2.598448,"median":-0.825353,"eighty":-0.45127,"marketCap":1897272},{"date":"2026-02-13","current":-0.247783,"twenty":-2.592001,"median":-0.81256,"eighty":-0.445188,"marketCap":1660113},{"date":"2026-02-20","current":-0.703104,"twenty":-2.58341,"median":-0.806258,"eighty":-0.445188,"marketCap":4710707},{"date":"2026-02-27","current":-0.610973,"twenty":-2.582485,"median":-0.794977,"eighty":-0.445586,"marketCap":4093442},{"date":"2026-03-06","current":-0.342097,"twenty":-2.577205,"median":-0.78801,"eighty":-0.445586,"marketCap":2292003},{"date":"2026-03-13","current":-0.355593,"twenty":-2.566434,"median":-0.778466,"eighty":-0.440568,"marketCap":2382428},{"date":"2026-03-20","current":-0.306295,"twenty":-2.548508,"median":-0.76506,"eighty":-0.437027,"marketCap":2052137},{"date":"2026-03-27","current":-0.151127,"twenty":-2.546818,"median":-0.759629,"eighty":-0.431287,"marketCap":1012532},{"date":"2026-04-02","current":-0.978399,"twenty":-2.542123,"median":-0.751181,"eighty":-0.429017,"marketCap":7580454},{"date":"2026-04-10","current":-1.314876,"twenty":-2.536364,"median":-0.763457,"eighty":-0.430278,"marketCap":10187415},{"date":"2026-04-17","current":-0.95241,"twenty":-2.532982,"median":-0.77507,"eighty":-0.431287,"marketCap":7379097},{"date":"2026-04-24","current":-0.834527,"twenty":-2.532982,"median":-0.784801,"eighty":-0.431287,"marketCap":6465759},{"date":"2026-05-01","current":-1.413088,"twenty":-2.507089,"median":-0.786351,"eighty":-0.43398,"marketCap":10948345},{"date":"2026-05-08","current":-1.240761,"twenty":-2.495456,"median":-0.794314,"eighty":-0.434538,"marketCap":9613181},{"date":"2026-05-15","current":-1.208099,"twenty":-2.495456,"median":-0.801613,"eighty":-0.436584,"marketCap":9360127},{"date":"2026-05-22","current":-0.679111,"twenty":-2.495456,"median":-0.797632,"eighty":-0.438798,"marketCap":7542626}],"updateTime":1779705617346},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELAB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635035716","title":"Elevai Labs Q1營收大幅下滑，淨虧損擴大","url":"https://stock-news.laohu8.com/highlight/detail?id=2635035716","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635035716?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 23:43","pubTimestamp":1778859780,"startTime":"0","endTime":"0","summary":"　　Elevai Labs公布2026年第一季度财报。公司报告期内营收为30.5万美元，相比去年同期的86.8万美元大幅下降65%。净亏损为222.9万美元，较去年同期的净亏损142.5万美元进一步扩大，合每股亏损0.13美元。　　Elevai Labs是一家专注于医学美容领域的生物技术公司，主要开发基于外泌体的创新护肤产品。公司同时强调了其在高端医美市场的产品布局，预计未来将通过扩大营销投入来提升品牌知名度和市场份额。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-15/doc-inhxyyii5160377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102597324","title":"納斯達克上市公司PMGC Holdings發布2026年第一季度財報並提交10-Q表格；總資產突破2600萬美元，較2025年底激增102%，按年飆升193%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102597324","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102597324?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 19:12","pubTimestamp":1778843558,"startTime":"0","endTime":"0","summary":"PMGC Holdings（纳斯达克股票代码：ELAB）公布了其2026年第一季度的财务业绩，并已向美国证券交易委员会提交了相应的10-Q表格。报告显示，公司总资产规模已超过2600万美元，这一数字与2025年年底相比实现了102%的惊人增长，与去年同期相比更是大幅跃升了193%。\n这份亮眼的资产增长数据，凸显了公司在过去一段时间内的快速扩张态势。提交10-Q表格是上市公司按季度向监管机构披露未经审计财务报表的法定义务，此举标志着公司已按时完成了本季度的财务信息披露工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162597728","title":"諾思創生物科學提交新美國專利申請 涵蓋EL-22製劑及給藥方案 用於治療GLP-1相關肌肉萎縮、少肌症、肌肉廢用性萎縮及特定神經系統疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=1162597728","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162597728?lang=zh_tw&edition=fundamental","pubTime":"2026-04-29 04:01","pubTimestamp":1777406480,"startTime":"0","endTime":"0","summary":"诺思创生物科学公司近日向美国专利商标局提交了一项新的专利申请，该申请全面覆盖其创新药物EL-22的制剂配方与给药方案。这项专利技术的治疗范围颇具前瞻性，主要针对四大疾病领域：GLP-1药物使用引发的肌肉萎缩并发症、老年性少肌症、肌肉废用性萎缩综合征，以及某些特定类型的神经系统疾病。在人口老龄化加剧的背景下，该专利涉及的少肌症治疗市场潜力巨大。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119387402","title":"Svm Machining與Turbo-Jet Products簽署長期協議，供應航空航天與國防關鍵部件","url":"https://stock-news.laohu8.com/highlight/detail?id=1119387402","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119387402?lang=zh_tw&edition=fundamental","pubTime":"2026-04-21 19:31","pubTimestamp":1776771107,"startTime":"0","endTime":"0","summary":"Svm Machining公司已与Turbo-Jet Products公司正式达成一项长期供应协议，将为后者提供用于航空航天与国防领域的关键任务部件。此次合作标志着Svm Machining在高精度制造领域的专业能力获得重要认可，同时也为Turbo-Jet Products公司确保了关键零部件供应链的稳定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188388695","title":"PMGC Holdings簽署4000萬美元股權融資協議 宣佈加速航空航天與國防制造領域併購戰略","url":"https://stock-news.laohu8.com/highlight/detail?id=1188388695","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188388695?lang=zh_tw&edition=fundamental","pubTime":"2026-04-17 19:32","pubTimestamp":1776425574,"startTime":"0","endTime":"0","summary":"PMGC Holdings（纳斯达克代码：ELAB）已成功获得4000万美元股权融资额度协议，此举将显著增强公司推进并购战略的资金实力。该战略当前聚焦于收购航空航天及国防制造领域的企业。\n通过这项融资安排，公司获得了可灵活调动的资本支持，为加速实施既定的并购计划创造了有利条件。此次融资将主要用于瞄准航空航天与国防制造行业的优质标的，进一步扩大公司在高精尖制造领域的产业布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122587787","title":"Northstrive Biosciences宣佈EL-32工作細胞庫運抵美國並啓動與Modulant Biosciences合作的雙重肌生長抑制素資產生產工藝優化，旨在結合GLP-1療法實現肌肉保護","url":"https://stock-news.laohu8.com/highlight/detail?id=1122587787","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122587787?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 19:35","pubTimestamp":1776080107,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences已正式宣布，其EL-32工作细胞库成功运抵美国。与此同时，公司与Modulant Biosciences展开合作，正式启动了针对双重肌生长抑制素资产的生产工艺优化项目。该项目核心目标在于，通过优化制造流程，开发能够与GLP-1疗法协同作用、专注于肌肉保护的新型疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115118521","title":"PMGC Holdings旗下Northstrive保留EL-32人權授權 Modulant獲獨家動物健康許可","url":"https://stock-news.laohu8.com/highlight/detail?id=1115118521","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115118521?lang=zh_tw&edition=fundamental","pubTime":"2026-04-13 19:34","pubTimestamp":1776080046,"startTime":"0","endTime":"0","summary":"PMGC Holdings宣布，其子公司Northstrive将保留EL-32化合物在人类医疗领域的全球开发与商业化权利。与此同时，合作企业Modulant获得了该化合物在动物健康领域的独家授权许可。\n此次授权划分明确了双方在EL-32应用领域的商业边界。Northstrive将继续推进EL-32在人类疾病治疗方面的临床研究，而Modulant将专注于开发针对伴侣动物和畜牧动物的新型治疗方案。\n这一战略安排有助于双方集中资源深耕各自专业领域，为EL-32的商业化路径提供更明确的发展方向。化合物授权范围的细分也体现了精准医疗时代下知识产权管理的精细化趋势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149227509","title":"Aga Precision Systems 再籤長期供應協議 為一階供應商製造航空航天與國防部件","url":"https://stock-news.laohu8.com/highlight/detail?id=1149227509","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149227509?lang=zh_tw&edition=fundamental","pubTime":"2026-04-09 19:32","pubTimestamp":1775734342,"startTime":"0","endTime":"0","summary":"Aga Precision Systems 公司近日宣布签署了第二份长期供应协议，将为一家一阶供应商制造航空航天与国防领域的关键部件。\n此项协议的达成，标志着公司在高精度制造领域的专业能力再次获得业界顶尖客户的认可，进一步巩固了其在供应链中的重要地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625706796","title":"BUZZ--美國股票走勢-泰森食品公司、Atmus 過濾公司、安飛士預算公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2625706796","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625706796?lang=zh_tw&edition=fundamental","pubTime":"2026-04-06 23:45","pubTimestamp":1775490340,"startTime":"0","endTime":"0","summary":"nL6N40P0AM ** Playtika Holding Corp PLTK.O:BUZZ - 在宣布审查战略备选方案后上涨 nL4N40P0GB ** Nvidia Corp NVDA.O：** Advanced Micro Devices Inc AMD.O：** 高通公司 QCOM.O：** Broadcom Inc AVGO.O:BUZZ - 行业组织称，2月份全球芯片销售额猛增62%。nL4N40P0JM ** Praxis Precision Medicines Inc PRAX.O:BUZZ - 因癫痫药物减少儿童癫痫发作而上涨 nL4N40P0NM ** Tyson Foods Inc TSN.N:BUZZ - Piper Sandler将Tyson Foods的评级提升至 \"增持\"。nL6N40P0E7 ** Atmus Filtration Technologies Inc ATMU.N:BUZZ--该公司将加入标准普尔小型股指数，股价上涨。nL6N40P0E2 ** Oncolytics Biotech Inc ONCY.O:BUZZ - 因该公司计划与美国食品及药物管理局就肛门癌药物进行谈判而上涨。nL4N40P0PL ** Carvana Co CVNA.N:BUZZ - 因美国银行将宏观","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nL4T40P0VT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMD","AESI","AVGG","NVD2.UK","OXY","WLK","CAR","ADM","DAMD","TSN","DVN","WTBA","AMYY","BKNG","NVD3.UK","ANV","LGN","NVDX","NVDY","ONCY","ELAB","AMDL","CVX","SLNO","KTUP","AMDY","NVDA","RKT","ATMU","PRAX","QCOM","IBRX","AGPU","DOW","CVNA","KTOS","BKNU","NVIW.SI","PFSA","NVDQ","AVGW","FAF","EXPE","IDYA","LYB","NVDB","XOM","AMDW","VLO","AVGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625967938","title":"BUZZ-PMGC 控股公司子公司獲得無人機技術選擇權，股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2625967938","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625967938?lang=zh_tw&edition=fundamental","pubTime":"2026-04-06 19:53","pubTimestamp":1775476426,"startTime":"0","endTime":"0","summary":"BUZZ-PMGC 控股公司子公司获得无人机技术选择权，股价下跌4月6日 - ** 国防科技公司PMGC Holdings ELAB.O股价盘前下跌11.1%至5.08美元** 该公司称其NorthStrive Defense Tech部门获得了一项美国专利的独家许可权，该专利涉及一种可在空中和水中作业的无人机系统。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nL4S40P0JX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155360655","title":"Northstrive Defense Tech 獲得多領域無人機載荷技術選項，用於國防與商業應用","url":"https://stock-news.laohu8.com/highlight/detail?id=1155360655","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155360655?lang=zh_tw&edition=fundamental","pubTime":"2026-04-06 19:31","pubTimestamp":1775475070,"startTime":"0","endTime":"0","summary":"Northstrive Defense Tech 已成功获得一项多领域无人机载荷技术的选择权，该技术旨在服务于国防和商业两大应用领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132535462","title":"PMGC Holdings Inc.宣佈成立新子公司Northstrive Defense Tech，瞄準高增長的國防、無人機及自主系統領域","url":"https://stock-news.laohu8.com/highlight/detail?id=1132535462","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132535462?lang=zh_tw&edition=fundamental","pubTime":"2026-04-03 04:06","pubTimestamp":1775160372,"startTime":"0","endTime":"0","summary":"PMGC Holdings Inc.正式宣布成立一家全新的子公司——Northstrive Defense Tech。这一战略举措旨在精准切入当前呈现高速增长态势的国防科技、无人机以及自主系统领域。新公司的成立标志着PMGC Holdings致力于拓展其在尖端技术市场的影响力，并把握该领域涌现的巨大商业机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124421697","title":"PMGC Holdings與Turbo-Jet Products簽署長期協議，供應關鍵航空航天與國防部件","url":"https://stock-news.laohu8.com/highlight/detail?id=1124421697","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124421697?lang=zh_tw&edition=fundamental","pubTime":"2026-03-31 19:31","pubTimestamp":1774956675,"startTime":"0","endTime":"0","summary":"PMGC Holdings已与Turbo-Jet Products达成一项长期供应协议，将为后者提供用于航空航天与国防领域的关键任务部件。这一合作标志着PMGC Holdings在高端精密制造领域的进一步拓展，有望巩固其在全球供应链中的战略地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164291688","title":"PMGC Holdings [納斯達克: ELAB] 公布2025年度業績並提交10-K表格，公司資產規模擴大至1380萬美元，較2024年增長43%","url":"https://stock-news.laohu8.com/highlight/detail?id=1164291688","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164291688?lang=zh_tw&edition=fundamental","pubTime":"2026-03-30 19:05","pubTimestamp":1774868717,"startTime":"0","endTime":"0","summary":"PMGC Holdings Inc.（纳斯达克代码：ELAB）正式披露2025财年完整年度财务报告，并向美国证券交易委员会提交Form 10-K文件。最新数据显示，公司总资产规模已攀升至1380万美元，较2024年同期实现43%的显著增长。\n此次资产规模的扩张印证了公司战略布局的有效性。通过优化资源配置与精准投资，PMGC Holdings在竞争激烈的市场环境中持续强化财务基础。10-K文件的提交进一步增强了企业透明度，为投资者提供更全面的决策依据。\n（注：原文中重复的标题信息已整合为连贯的正文内容）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132477234","title":"Northstrive Biosciences與Moa Life Plus簽署許可協議修正案，共同開發靶向肌肉保留的雙重肌肉生長抑制素資產，以聯合GLP-1療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1132477234","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132477234?lang=zh_tw&edition=fundamental","pubTime":"2026-03-28 04:06","pubTimestamp":1774641974,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences已与Moa Life Plus [Kosdaq: 142760]签署了一项许可协议修正案。此次合作的核心在于共同开发靶向肌肉保留的双重肌肉生长抑制素资产，旨在将其与GLP-1疗法结合使用。这一举措有望为相关治疗领域带来新的协同效应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159921822","title":"SVM Machining公司成功獲得ITAR註冊資格，正式進軍美國國防制造合同領域","url":"https://stock-news.laohu8.com/highlight/detail?id=1159921822","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159921822?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 19:07","pubTimestamp":1774350477,"startTime":"0","endTime":"0","summary":"SVM Machining公司近日已正式获得国际武器贸易条例（ITAR）注册认证。这一重要资质使该公司有资格参与美国国防制造领域的合同项目，为其业务拓展打开了新的战略通道。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165017829","title":"Northstrive Biosciences啓動El-32臨床前研究，評估GLP-1減重療法中的肌肉保護作用","url":"https://stock-news.laohu8.com/highlight/detail?id=1165017829","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165017829?lang=zh_tw&edition=fundamental","pubTime":"2026-03-10 19:31","pubTimestamp":1773142289,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences公司宣布，正式启动其候选药物El-32的临床前研究。该研究旨在评估El-32在GLP-1受体激动剂类减重疗法中，对于肌肉组织的保护功效。随着GLP-1药物在体重管理领域的广泛应用，如何有效防止治疗过程中可能伴随的肌肉流失，已成为行业关注的焦点。此次研究的启动，标志着Northstrive Biosciences在探索减重疗法优化方案方面迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128622806","title":"Northstrive Biosciences簽署最終許可協議，推進肌肉抑制素工程益生菌El-22與El-32在動物健康領域的商業化進程","url":"https://stock-news.laohu8.com/highlight/detail?id=1128622806","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128622806?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 20:30","pubTimestamp":1770813014,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences公司已正式签署一项最终许可协议，旨在推动其创新产品El-22与El-32的商业化应用。这两种产品是基于肌肉抑制素（Myostatin）工程改造的益生菌，专门用于动物健康领域的肌肉维持，标志着该技术在畜牧与伴侣动物营养管理方面迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195857161","title":"PMGC Holdings旗下Northstrive Biosciences與Modulant Biosciences達成許可協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1195857161","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195857161?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 05:41","pubTimestamp":1770759682,"startTime":"0","endTime":"0","summary":"PMGC Holdings Inc（股票代码：ELAB）宣布，其子公司Northstrive Biosciences已与Modulant Biosciences签署许可协议。该协议于近日通过美国证券交易委员会（SEC）文件正式披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603967188","title":"Pmgc Holdings Inc.盤中異動 股價大跌6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603967188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603967188?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 22:42","pubTimestamp":1768401764,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日22时42分，Pmgc Holdings Inc.股票出现波动，股价大幅下挫6.09%。截至发稿，该股报3.78美元/股，成交量5.1316万股，换手率4.33%，振幅6.47%。Pmgc Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Pmgc Holdings Inc.公司简介：PMGC Holdings Inc 在医学美学和生物制药创新方面取得进展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114224244a71ab023&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114224244a71ab023&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELAB","BK4183"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}]}}